Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer

Journal: Nature Communications

Published: 2020-06-24

DOI: 10.1038/s41467-020-16711-w

Affiliations: 59

Authors: 86

Go to article
Institutions Share
National Cancer Center (NCC), Japan 0.08
Aichi Cancer Center, Japan 0.08
The University of Tokyo (UTokyo), Japan 0.07
Kanagawa Cancer Center, Japan 0.06
RIKEN Center for Integrative Medical Sciences (IMS), Japan 0.06
Aichi Medical University, Japan 0.05
Nagoya University, Japan 0.05
Cancer Institute Hospital, JFCR, Japan 0.05
Osaka University, Japan 0.05
Kyoto University, Japan 0.03
University of Southern California (USC), United States of America (USA) 0.03
Tohoku Medical Megabank Organization (ToMMo), Tohoku University, Japan 0.03
Iwate Tohoku Medical Megabank Organization (IMM), Japan 0.03
Aichi Cancer Center Hospital, Japan 0.02
National Cancer Center Hospital, Japan 0.02
University of Hawai'i at Manoa (UH Mānoa), United States of America (USA) 0.02
Kyorin University, Japan 0.02
NIH National Cancer Institute (NCI), United States of America (USA) 0.02
Nagoya University Hospital, Japan 0.02
Kyushu University, Japan 0.02
Nagoya City University, Japan 0.01
Chiba Cancer Center Research Institute (CCCRI), Japan 0.01
Kagoshima University, Japan 0.01
Yale University, United States of America (USA) 0.01
Shiga University of Medical Science (SUMS), Japan 0.01
University of Shizuoka, Japan 0.01
Kyoto Prefectural University of Medicine (KPUM), Japan 0.01
Hiroshima University (HU), Japan 0.01
Hyogo College of Medicine, Japan 0.01
Sapporo Shirakabadai Hospital, Japan 0.01
Hokkaido Chitose College of Rehabilitation, Japan 0.01
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan 0.01
Tokyo Metropolitan Hiroo Hospital, Japan 0.01
Chiba Cancer Center, Japan 0.01
Iwate Medical University, Japan 0.01
Tokushima University, Japan 0.01